Bifidobacterium infantis strains with and without a combination of Oligofructose and Inulin (OFI) attenuate inflammation in DSS-induced colitis in rats

被引:107
作者
Osman, Nadia
Adawi, Diya [1 ]
Molin, Goran
Ahrne, Siv
Berggren, Anna
Jeppsson, Bengt
机构
[1] Lund Univ, Dept Food Technol Engn & Nutr, S-20502 Malmo, Sweden
[2] Lund Univ, Malmo Univ Hosp, Dept Surg, S-20502 Malmo, Sweden
[3] Probi AB, Lund, Sweden
关键词
D O I
10.1186/1471-230X-6-31
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background: Pathogenesis of inflammatory bowel disease is thought to be through different factors and there is a relationship between the gut flora and the risk of its development. Probiotics can manipulate the microflora in chronic inflammation and may be effective in treating inflammation. Bifidobacterium are saccharolytic and their growth in the gut can be promoted by non- absorbable carbohydrates and its increase in the colon appears to be of benefit. Methods: Oligofructose and inulin ( OFI) alone and the two B. infantis DSM 15158 and DSM 15159 with and without OFI, were fed to Sprague- Dawley rats for 7 days prior to colitis induction and administrations continued for another 7 days with the DSS. Colitis severity assessed using a Disease Activity Index. Samples were collected 7 days after colitis induction, for intestinal bacterial flora, bacterial translocation, short chain fatty acids ( SCFAs), myeloperoxidase ( MPO), cytokines ( IL- 1 beta, TNF-alpha, IL- 10 and TGF-beta) and malondialdehyde ( MDA). Results: OFI alone or the B. infantis strains with and without OFI improved significantly the DAI and decreased colonic MPO activity. Colonic tissue IL- 1 beta decreased significantly in all treated groups except B. infantis DSM 15158. MDA decreased significantly in B. infantis DSM 15159 with and without OFI compared to colitis control. Succinic acid increased significantly in OFI group with and without DSM 15159 compared to all groups. Sum values of propionic, succinic acid and butyric acid increased significantly in all groups compare to the colitis control. Bacterial translocation to mesenteric lymph nodes decreased significantly in all groups compared to colitis control. Translocation to the liver decreased significantly in all groups compare to the colitis control and OFI + B. infantis DSM 15158 groups. Conclusion: Administrations of OFI and Bifidobacterium improve DSS- induced acute colitis and have an anti- inflammatory effect. Major differences in effect were observed between the two B. infantis strains as indicated in MDA and succinic acid concentration as well as bacterial translocation rate in synbiotic combinations.
引用
收藏
页数:10
相关论文
共 35 条
[1]   Involvement of interleukin-1 in the development of ulcerative colitis induced by dextran sulfate sodium in mice [J].
Arai, Y ;
Takanashi, H ;
Kitagawa, H ;
Okayasu, I .
CYTOKINE, 1998, 10 (11) :890-896
[2]  
Araki Y, 2003, INT J MOL MED, V12, P125
[3]   In situ expression of interleukin-10 in noninflamed human gut and in inflammatory bowel disease [J].
Autschbach, F ;
Braunstein, J ;
Helmke, B ;
Zuna, I ;
Schürmann, G ;
Niemir, ZI ;
Wallich, R ;
Otto, HF ;
Meuer, SC .
AMERICAN JOURNAL OF PATHOLOGY, 1998, 153 (01) :121-130
[4]   Increased mucosal tumour necrosis factor α production in Crohn's disease can be downregulated ex vivo by probiotic bacteria [J].
Borruel, N ;
Carol, M ;
Casellas, F ;
Antolín, M ;
de Lara, F ;
Espín, E ;
Naval, J ;
Guarner, F ;
Malagelada, JR .
GUT, 2002, 51 (05) :659-664
[5]   Differential effects of short-chain fatty acids on proliferation and production of pro- and anti-inflammatory cytokines by cultured lymphocytes [J].
Cavaglieri, CR ;
Nishiyama , A ;
Fernandes, LC ;
Curi, R ;
Miles, EA ;
Calder, PC .
LIFE SCIENCES, 2003, 73 (13) :1683-1690
[6]  
COOPER HS, 1993, LAB INVEST, V69, P238
[7]  
Forrest CM, 2003, ADV EXP MED BIOL, V527, P395
[8]   Synbiotic therapy (Bifidobacterium longum/Synergy 1) initiates resolution of inflammation in patients with active ulcerative colitis:: a randomised controlled pilot trial [J].
Furrie, E ;
Macfarlane, S ;
Kennedy, A ;
Cummings, JH ;
Walsh, SV ;
O'Neil, DA ;
Macfarlane, GT .
GUT, 2005, 54 (02) :242-249
[9]   IL-10 secretion and sensitivity in normal human intestine and inflammatory bowel disease [J].
Gasche, C ;
Bakos, S ;
Dejaco, C ;
Tillinger, W ;
Zakeri, S ;
Reinisch, W .
JOURNAL OF CLINICAL IMMUNOLOGY, 2000, 20 (05) :362-370
[10]   Role of bacteria in experimental colitis [J].
Guarner, F ;
Malagelada, JR .
BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY, 2003, 17 (05) :793-804